The “Flesh Without Blood” singer put a timeline on the plans, stating: “Let’s aim for chips by 2022. It’s experimental surgery but if it succeeds we’ll have the knowledge of the Gods haha.”
Lil Uzi agreed, writing: “Okay!!! I will call u for more detail.”
Nanoscale doctors curing the body from within sounds like science fiction, but for Japanese research centre COINS, it’s a serious goal.
This is the FOURTH PART of the interview with Harold Katcher in Modern Healthspan YouTube channel.
Dr. Harold Katcher is a professor of Biology at the University of Maryland. He has been a pioneer in the field of cancer research, in the development of modern aspects of gene hunting and sequencing. He carries expertise in bioinformatics, chronobiology, and biotechnology. Dr. Katcher is currently working in the capacity of Chief Technical Officer at Nugenics Research exploring rejuvenation treatments in mammals.
In May 2020 there was a paper published on biorxiv about the rejuvenation of rats by over 50%. We did a review of the paper which you can find linked to above. In this interview series we talk with Dr. Harold Katcher, one of the main authors of the paper about the experiment, the steps to get validation, commercialization and how the results fit into his theories of aging.
In this video Dr. Katcher explains his theories on what causes aging, which he believes is a process that is programmed into us and is therefore malleable. I find his theories very interesting and compelling.
A new type of quantum holography which uses entangled photons to overcome the limitations of conventional holographic approaches could lead to improved medical imaging and speed the advance of quantum information science.
There’s a mini second genome inside your cells, but no one could figure out how to edit it — until now.
Human-Autonomy Interaction, Collaboration and Trust — Dr. Julie Marble, JHU Applied Physics Laboratory (APL)
Dr. Julie Marble is a senior scientist at the Johns Hopkins University Applied Physics Laboratory (JHUAPL) leading research in human-autonomy interaction, collaboration and trust.
Dr. Marble earned her PhD in Human Factors/Cognitive Psychology from Purdue University. After graduating from Purdue University, she joined the Idaho National Laboratory (INL), one of the national laboratories of the United States Department of Energy involved in nuclear research, first in the Human Factors group and then the Human and Robotic Systems group.
We can immediately supersede the Mojo Vision approach for retinal projection, with an interim projection system using metalenses. The Mojo Lens approach is to try to put everything, including the television screen, projection method and energy source onto one contact lens. With recent breakthroughs in scaling up the size of metalenses, an approach utilizing a combination of a contact metalens and a small pair of glasses can be utilized. This is emphatically not the Google Glass approach, which did not use modern metalenses. The system would work as follows:
1)Thin TV cameras are mounted on both sides of a pair of wearable glasses.
2)The images from these cameras are projected via projection metalenses in a narrow beam to the center of the pupils.
3)A contact lens with a tiny metalens mounted in the center, directly over the pupil, projects this projected beam outwards, through the pupil, onto the full width of the curved retina.
The end result would be a 360 degree, full panorama image. This image can either be a high resolution real time vision of the wearer’s surroundings, or can be a projection of a movie, or augmented reality superimposed on the normal field of vision. It can inherently be full-color 3D. Of course such a system will be complemented with ear phones. Modern hearing aids are already so small they can barely be seen, and have batteries that last a week. A pair of ear phones will also allow full 3D sound and also will be the audible complement of augmented vision.
The U.S. military routinely deploys throughout the world where warfighters can potentially be exposed to regional endemic diseases as well as chemical, biological, radiological, or nuclear (CBRN) threats. Rapid access to medical countermeasures (MCMs) against these threats is critical to protect Defense Department (DoD) personnel and local populations; however, manufacturing, stockpiling, and distribution issues remain.
A pacesetting institution, the Icahn School of Medicine at Mount Sinai is opening a psychedelic research center focusing on MDMA and trauma.
It’s too early to call it a miracle cure, but if the conclusions from a recent Phase 1 trial for a new drug called EXO-C24 are backed up in subsequent trials, we might have the first true breakthrough therapy for COVID-19. That’s in addition to coronavirus vaccines, of course, which will help prevent severe COVID-19 cases and deaths, and even reduce the spread of the illness. But while vaccines can give the immune system a heads-up to the threat it might have to deal with — the real virus — they have a few limitations. First of all, they don’t work on infected people. Secondly, vaccine supply is still limited and vaccinations aren’t available to anybody who might want one. Then there’s the threat of coronavirus mutations that might reduce vaccines’ effect on the virus and extend the pandemic.
